Business Context and Reporting Period
Company: Cardinal Health, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended March 31, 1999 (Fiscal Year 1999)
Business Overview: Cardinal Health operates in pharmaceutical distribution, healthcare services, and medical/surgical product manufacturing. The financial statements have been restated to reflect the pooling of interests with MediQual (1998), R.P. Scherer (1998), and Allegiance Corporation (February 3, 1999).
Key Financial Metrics
| Metric (in millions) | 3 Months Ended Mar 31, 1999 | 9 Months Ended Mar 31, 1999 |
|---|---|---|
| Total Revenue | $6,433.4 | $18,483.5 |
| Operating Revenue | $5,558.7 | $15,827.3 |
| Gross Margin | $667.3 | $1,894.4 |
| Operating Earnings | $190.6 | $613.6 |
| Net Earnings | $81.9 | $306.9 |
| Diluted EPS | $0.29 | $1.10 |
| Cash and Equivalents | $175.6 | $175.6 (Ending Balance) |
| Working Capital | $2,382.3 | $2,382.3 (Ending Balance) |
| Long-Term Obligations | $1,540.8 | $1,540.8 (Ending Balance) |
Margin Analysis: Gross margin as a percentage of operating revenue was 12.01% for the quarter and 11.97% for the nine-month period, down from 12.33% and 12.29% in the prior year, respectively.
Material Changes vs. Prior Period
- Revenue Growth: Operating revenue increased 20% year-over-year for both the three and nine-month periods. Distribution business revenue grew 25% (quarter) and 27% (nine months), driven by chain drugstore sales.
- Profitability Decline: Net earnings decreased 25% for the quarter ($81.9M vs. $109.2M) despite revenue growth. This was primarily due to significant merger-related costs.
- Merger Costs: Merger-related costs totaled $87.5 million for the quarter and $125.0 million for the nine months ended March 31, 1999, compared to $21.2 million and $26.6 million in the prior year periods. These costs reduced net earnings by $74.2 million (quarter) and $103.9 million (nine months) on a net-of-tax basis.
- Cash Flow: Net cash provided by operating activities turned negative at $(173.2) million for the nine months ended March 31, 1999, compared to $128.1 million in the prior year. This was driven by a $531.6 million increase in merchandise inventories and a $241.3 million increase in trade receivables.
- Debt and Liquidity: Working capital increased to $2.4 billion. The company entered into a $250 million short-term and $750 million long-term revolving credit facility on March 31, 1999, with no amounts outstanding at period end.
Guidance, Outlook, and Risks
- Future Merger Costs: Management estimates an additional $123.1 million ($75.4 million net of tax) in merger-related costs will be incurred in future periods (primarily fiscal 1999 and 2000) to integrate Scherer and Allegiance operations.
- Year 2000 Compliance: The company estimates total project costs of approximately $27.0 million. It intends to complete remediation for business-critical systems by June 30, 1999. While no material adverse impact is anticipated, risks include potential disruption of operations or communication services.
- Legal Proceedings:
- Latex Litigation: Approximately 400 lawsuits regarding natural rubber latex sensitization were pending as of April 30, 1999. The company cannot estimate potential loss but expects significant defense expenses.
- Antitrust: A consolidated class action lawsuit regarding chargeback pricing resulted in a judgment in favor of the defendants in November 1998; plaintiffs filed an appeal in January 1999. Exposure is limited to $1 million or 1% of any judgment.
- Market Risk: No material change in exposure to market risk was reported. The company does not expect the Euro conversion to have a material impact on financial statements.
Investor Verification Checklist
- Merger Integration Costs: Verify the trajectory of the estimated $123.1 million in future merger-related expenses and their impact on upcoming earnings.
- Working Capital Efficiency: Monitor the $531.6 million increase in inventory and $241.3 million increase in receivables to ensure they align with revenue growth and do not signal collection or obsolescence issues.
- Latex Litigation Exposure: Track the status of the ~400 pending latex lawsuits and the associated defense costs, as the company currently cannot quantify potential liability.
- Year 2000 Readiness: Confirm the completion of remediation and testing for critical systems by the June 30, 1999 deadline to mitigate operational disruption risks.
- Margin Compression: Analyze the continued decline in gross margin percentages (down to ~12%) to determine if competitive pricing pressures in the distribution sector are sustainable.